Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 StudyJ. Clin. Oncol 2021 Sep 07;[EPub Ahead of Print], SK Pal, B McGregor, C Suárez, CK Tsao, W Kelly, U Vaishampayan, L Pagliaro, BL Maughan, Y Loriot, D Castellano, S Srinivas, RR McKay, R Dreicer, T Hutson, S Dubey, S Werneke, A Panneerselvam, D Curran, C Scheffold, TK Choueiri, N Agarwal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.